{"AllianceGenome": "612", "HGNC": "612", "MIM": "107740", "_id": "347", "_version": 1, "accession": {"genomic": ["AB839003.1", "AC069213.22", "AH002605.2", "CH471052.2", "CP068275.2", "NC_000003.12", "NC_060927.1"], "protein": ["AAA51764.1", "AAB35919.1", "AAB59517.1", "AAH07402.1", "AAV38663.1", "AAV38664.1", "BAG35026.1", "BAG57734.1", "CAG33119.1", "CAG46572.1", "EAW78023.1", "EAW78024.1", "NP_001638.1", "P05090.1"], "rna": ["AK294523.1", "AK312090.1", "BC007402.2", "BQ008672.1", "BT019860.1", "BT019861.1", "BU195270.1", "BU727194.1", "CR456838.1", "CR541773.1", "DA892855.1", "J02611.1", "NM_001647.4", "S80440.1"], "translation": [{"protein": "AAH07402.1", "rna": "BC007402.2"}, {"protein": "AAB59517.1", "rna": "J02611.1"}, {"protein": "AAV38664.1", "rna": "BT019861.1"}, {"protein": "AAV38663.1", "rna": "BT019860.1"}, {"protein": "BAG57734.1", "rna": "AK294523.1"}, {"protein": "CAG33119.1", "rna": "CR456838.1"}, {"protein": "BAG35026.1", "rna": "AK312090.1"}, {"protein": "AAB35919.1", "rna": "S80440.1"}, {"protein": "NP_001638.1", "rna": "NM_001647.4"}, {"protein": "CAG46572.1", "rna": "CR541773.1"}]}, "ensembl": {"gene": "ENSG00000189058", "protein": ["ENSP00000345179", "ENSP00000391597", "ENSP00000393076", "ENSP00000415235"], "transcript": ["ENST00000343267", "ENST00000421243", "ENST00000453131", "ENST00000458447", "ENST00000463719"], "translation": [{"protein": "ENSP00000345179", "rna": "ENST00000343267"}, {"protein": "ENSP00000391597", "rna": "ENST00000458447"}, {"protein": "ENSP00000415235", "rna": "ENST00000421243"}, {"protein": "ENSP00000393076", "rna": "ENST00000453131"}], "type_of_gene": "protein_coding"}, "entrezgene": "347", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 5.99672049, "exp_mis": 66.2308326, "exp_syn": 37.584392, "lof_z": 0.403186631658905, "mis_z": -0.166431698137803, "mu_lof": 3.81311162879e-07, "mu_mis": 5.69755139877e-06, "mu_syn": 3.16922745133e-06, "n_lof": 5.0, "n_mis": 69.0, "n_syn": 36.0, "p_li": 0.000853904292818293, "p_null": 0.443262192713172, "p_rec": 0.55588390299401, "syn_z": 0.16021671264415}, "bp": 570, "cds_end": 195306332, "cds_start": 195295770, "n_exons": 4, "nonpsych": {"exp_lof": 5.3450683, "exp_mis": 59.8627539, "exp_syn": 33.9349646, "lof_z": 0.571372977034192, "mis_z": -0.00894737608248506, "mu_lof": 3.81311162879e-07, "mu_mis": 5.69755139877e-06, "mu_syn": 3.16922745133e-06, "n_lof": 4.0, "n_mis": 60.0, "n_syn": 33.0, "p_li": 0.00467922965349397, "p_null": 0.342980619438661, "p_rec": 0.652340150907846, "syn_z": 0.101049201461738}, "nontcga": {"exp_lof": 5.50893729, "exp_mis": 60.9243246, "exp_syn": 34.5696019, "lof_z": 0.213900409702103, "mis_z": -0.0686587260287401, "mu_lof": 3.81311162879e-07, "mu_mis": 5.69755139877e-06, "mu_syn": 3.16922745133e-06, "n_lof": 5.0, "n_mis": 62.0, "n_syn": 35.0, "p_li": 0.000674474494299395, "p_null": 0.493420830278233, "p_rec": 0.505904695227468, "syn_z": -0.0463497505399567}, "transcript": "ENST00000343267.3"}, "exons": [{"cdsend": 195579461, "cdsstart": 195568899, "chr": "3", "position": [[195568704, 195569135], [195571276, 195571365], [195573849, 195573971], [195579338, 195579495], [195583877, 195583940]], "strand": -1, "transcript": "NM_001647", "txend": 195583940, "txstart": 195568704}], "exons_hg19": [{"cdsend": 195306332, "cdsstart": 195295770, "chr": "3", "position": [[195295575, 195296006], [195298147, 195298236], [195300720, 195300842], [195306209, 195306366], [195310748, 195310811]], "strand": -1, "transcript": "NM_001647", "txend": 195310811, "txstart": 195295575}], "generif": [{"pubmed": 12052480, "text": "Observational study of genotype prevalence and gene-disease association. (HuGE Navigator)"}, {"pubmed": 12363390, "text": "Altered levels of apoD may help to understand the nature and possible mechanism of phospholipid membrane pathology in schizophrenia."}, {"pubmed": 12497622, "text": "Data suggest that the risk of Alzheimer disease among African-Americans may be modified by genetic variation in APOD."}, {"pubmed": 12497622, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12837283, "text": "APOD is a senescence-associated gene in normal human oral keratinocytes."}, {"pubmed": 12873803, "text": "Apolipoprotein D levels are elevated in prefrontal cortex of subjects with Alzheimer's disease, suggesting that it may be related to the cognitive decline observed in AD patients."}, {"pubmed": 12873803, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 14551159, "text": "ApoD selectively modulates the proliferative response of vascular smooth muscle cells to growth factors by a mechanism related to nuclear translocation of ERK1/2."}, {"pubmed": 14596852, "text": "In a study comparing brains from Alzheimer's patients and controls, it was found that hippocampal apolipoprotein D level depends on Braak stage and APOE genotype."}, {"pubmed": 15192024, "text": "ApoD can be expressed or taken up by SMCs and can regulate their motility in response to growth factors."}, {"pubmed": 15316799, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15316799, "text": "The -352G allele was associated with a significant 3-fold increase in the risk of early-onset Alzheimer's disease (OR: 2.7; 95% CI: 1.1-6.5). The -352G containing haplotypes were more common for early-onset Alzheimer's disease cases."}, {"pubmed": 15916898, "text": "Elevated apoD in AD brain may influence Abeta aggregation, or facilitate phagocytosis and transport of Abeta fibrils from plaques to cerebral vasculature."}, {"pubmed": 16402085, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16437381, "text": "study of the presence of apo D in the substantia nigra of control and Parkinson disease (PD) subjects; dopaminergic neurons were not immunoreactive for apo D but surrounding glial cells showed immunostaining for apo D and signal increases in PD cases"}, {"pubmed": 16966838, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17601350, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17885669, "text": "Apo D differentiates superficial acral fibromyxoma from dermatofibrosarcoma protuberans."}, {"pubmed": 18330697, "text": "ApoD positive tumors had both a significantly shorter relapse-free survival (all locations) and a decreased breast cancer-specific survival."}, {"pubmed": 18419796, "text": "These observations, together with its transcriptional up-regulation in the brain upon oxidative insult, identify ApoD as an acute response protein with a protective and therefore beneficial function mediated by the control of peroxidated lipids."}, {"pubmed": 18458334, "text": "ApoD and its orthologs play an evolutionarily conserved role in response to stress, possibly managing or preventing lipid peroxidation."}, {"pubmed": 18671953, "text": "Logistic analysis revealed that both APOD rs5952 C and rs1568566 T alleles increase the risk of sporadic Alzheimer's disease. The rs5952T-rs1568566C haplotype showed lower risk."}, {"pubmed": 18671953, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18842892, "text": "Role for apoD in regulation of inflammation. It may protect from HCoV-OC43-induced encephalitis, most likely through phospholipase A2 signaling pathways."}, {"pubmed": 18977241, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18979643, "text": "study demonstrated that Apo D was highly expressed in the mRNA and protein levels in human failing hearts compared with non-failing hearts"}, {"pubmed": 19176353, "text": "Variations in the levels and/or sites of apoD expression influence the lipid and glucose metabolism, consolidating apoD as a target for insulin-resistance-related disorders."}, {"pubmed": 19330472, "text": "Apolipoprotein D (APOD) and two further transcripts were significantly upregulated by dihydrotestosterone (DHT) in scrotum fibroblasts"}, {"pubmed": 19519777, "text": "apoD expression is increased throughout life in the human prefrontal cortex"}, {"pubmed": 19723339, "text": "The decrease in plasma ApoD concentration during pregnancy is an adaptive response aimed at maintaining fetal lipid homeostasis."}, {"pubmed": 19878569, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19944460, "text": "A strong relationship with gestational diabetes and APOD in the placenta that may reflect its suggested function in defense mechanisms against oxidative stress."}, {"pubmed": 20430392, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20493910, "text": "Importance of Parp-1, APEX-1 and ERK1/2 catalytic activities in the growth arrest-induced apoD gene expression."}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20855565, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21429623, "text": "Our findings show that Apo D expression is influenced by age, Braak stage, and sex."}, {"pubmed": 21526344, "text": "increased JNK1 activation in the apocrine cells from axillary osmidrosis contributes to the increased ApoD expression"}, {"pubmed": 21705670, "text": "Endothelial cells downregulate apolipoprotein D expression in mural cells through paracrine secretion and Notch3 signaling."}, {"pubmed": 22479522, "text": "Molecular dynamics analysis of apolipoprotein-D-lipid hydroperoxide interactions show the mechanism for selective oxidation of Met-93"}, {"pubmed": 23296401, "text": "ApoD is marker of initial stages of colorectal cancer progression."}, {"pubmed": 23690001, "text": "Rs7659, 3' UTR polymorphism of the APOD gene was associated with early onset Alzheimer disease in APOEepsilon4 (-) subgroup. Our results suggest that the variation of the APOD gene modifies the risk for Alzheimer disease."}, {"pubmed": 23715769, "text": "ApoE is located in the nucleus and on the ApoD promoter in human hepatic and glioblastoma cells lines."}, {"pubmed": 23777559, "text": "Data suggest that ApoD binds various lyophilic ligands: retinoic acid, retinol, fatty acids, sphingomyelin, and anandamide. ApoD successfully delivers retinoic acid to immature neuronal cell line resulting in neurogenesis (i.e., neurite formation)."}, {"pubmed": 23895740, "text": "ApoD mRNA expression is seen in whole endometrium, stromal and epithelial cells in the secretory phase, as well as after hormonal stimulation in vitro."}, {"pubmed": 24167586, "text": "We propose that strong brainstem expression of Apo D throughout adult life contributes to resistance against neurodegenerative disease and age-related degeneration, possibly by preventing oxidative stress and ensuing lipid peroxidation."}, {"pubmed": 25261976, "text": "The SNP rs7659 within the APOD gene might be related to risk and severity of ischemic stroke in patients."}, {"pubmed": 25513803, "text": "apoD mediates binding of high density lipoprotein to low density lipoprotein and to growing T24 carcinomas, thereby highlighting the importance of apoD in lipid metabolism."}, {"pubmed": 25918162, "text": "The internalization of apoD is mediated by basigin."}, {"pubmed": 25953740, "text": "The data suggest that the presence of Apo D in the nucleus, which some authors related with a specific transport, is a consequence of structural and functional alterations during oxidative stress"}, {"pubmed": 26083030, "text": "hepatic steatosis observed in apoD Tg mice is a consequence of increased PPARgamma transcriptional activity by AA leading to increased fatty acid uptake by the liver"}, {"pubmed": 26826316, "text": "Our results provide a viable solution to the production of recombinant ApoD protein in lieu of previous obstacles in generating soluble and functional ApoD protein"}, {"pubmed": 26829325, "text": "apoD protein levels are variable across different brain regions."}, {"pubmed": 27197790, "text": "This study demonstrated that Apo D is mainly located in glial cells while Apo J expression preferentially occurs in neurons in brain with patient with Alzheimer's Disease."}, {"pubmed": 27271124, "text": "These results provide additional mechanistic information on the apoD-mediated neuroprotection in neurodegenerative conditions."}, {"pubmed": 27804940, "text": "The high rate of APOD expression in HGPIN and cancer, as well as the absence of its expression in the vast majority of morphologically normal glands allows the use of this protein as an additional marker in the differential diagnosis of prostatic neoplasms."}, {"pubmed": 28301514, "text": "ApoD expression is likely not a predictor of recurrence in tamoxifen-treated patients. IMPACT: This study eliminates the previously suggested marker ApoD as a predictor of recurrence among tamoxifen-treated women"}, {"pubmed": 29222871, "text": "Study shows that in myelin maturation ApoD ultimately controls the removal of the sialic-rich hydrophilic glycocalyx, by maintaining functional integrity of lysosomes. A detailed analysis of the mechanism reveals that the proper localization of Neu1 and plasma membrane Neu3, as well as of the membrane-bound Fyn kinase, depend on ApoD."}, {"pubmed": 29869155, "text": "Association of higher ApoD levels in fat depots with improved metabolic health in severely obese women."}, {"pubmed": 30353968, "text": "HDX-MS reveals orthosteric and allosteric changes in apolipoprotein-D structural dynamics upon binding of progesterone."}, {"pubmed": 30630053, "text": "Study uncovered processes through which ApoD can modulate hepatic prostaglandin production and omega fatty acid accumulation, resulting in a non-inflammatory hepatic steatosis in transgenic hApoD mice. The accumulation of several omega fatty acids species in the transgenic mouse liver suggests that ApoD might bind to a broader range of fatty acids than previously thought."}, {"pubmed": 31779197, "text": "LCAT, ApoD, and ApoA1 Expression and Review of Cholesterol Deposition in the Cornea."}, {"pubmed": 31872472, "text": "Apolipoprotein D: a potential biomarker for cerebral amyloid angiopathy."}, {"pubmed": 31994214, "text": "Elevated levels of tumour apolipoprotein D independently predict poor outcome in breast cancer patients."}, {"pubmed": 32798728, "text": "Apolipoprotein D-mediated preservation of lysosomal function promotes cell survival and delays motor impairment in Niemann-Pick type A disease."}, {"pubmed": 32921312, "text": "Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis."}, {"pubmed": 33514021, "text": "Neuroprotective Effect of Apolipoprotein D in Cuprizone-Induced Cell Line Models: A Potential Therapeutic Approach for Multiple Sclerosis and Demyelinating Diseases."}, {"pubmed": 36571249, "text": "Identification of Apolipoprotein D as a Dermal Fibroblast Marker of Human Aging for Development of Skin Rejuvenation Therapy."}, {"pubmed": 37728985, "text": "APOD acts on fibroblast-like synoviocyte and chondrocyte to alleviate the process of osteoarthritis in vitro."}], "genomic_pos": {"chr": "3", "end": 195584033, "ensemblgene": "ENSG00000189058", "start": 195568705, "strand": -1}, "genomic_pos_hg19": {"chr": "3", "end": 195311076, "start": 195295573, "strand": -1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0000302", "qualifier": "involved_in", "term": "response to reactive oxygen species"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0000302", "pubmed": 18419796, "qualifier": "involved_in", "term": "response to reactive oxygen species"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0001525", "pubmed": 21705670, "qualifier": "involved_in", "term": "angiogenesis"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006006", "pubmed": 19176353, "qualifier": "involved_in", "term": "glucose metabolic process"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006629", "qualifier": "involved_in", "term": "lipid metabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006629", "pubmed": 19176353, "qualifier": "involved_in", "term": "lipid metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006869", "qualifier": "involved_in", "term": "lipid transport"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0007420", "qualifier": "involved_in", "term": "brain development"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0010642", "pubmed": 14551159, "qualifier": "involved_in", "term": "negative regulation of platelet-derived growth factor receptor signaling pathway"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0014012", "qualifier": "involved_in", "term": "peripheral nervous system axon regeneration"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0042246", "qualifier": "involved_in", "term": "tissue regeneration"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0042308", "pubmed": 14551159, "qualifier": "involved_in", "term": "negative regulation of protein import into nucleus"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0048662", "pubmed": 14551159, "qualifier": "involved_in", "term": "negative regulation of smooth muscle cell proliferation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0048678", "qualifier": "involved_in", "term": "response to axon injury"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0051895", "pubmed": 21705670, "qualifier": "involved_in", "term": "negative regulation of focal adhesion assembly"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0060588", "pubmed": 18419796, "qualifier": "involved_in", "term": "negative regulation of lipoprotein lipid oxidation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0071638", "pubmed": 18842892, "qualifier": "involved_in", "term": "negative regulation of monocyte chemotactic protein-1 production"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:1900016", "pubmed": 18842892, "qualifier": "involved_in", "term": "negative regulation of cytokine production involved in inflammatory response"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:2000098", "pubmed": 21705670, "qualifier": "involved_in", "term": "negative regulation of smooth muscle cell-matrix adhesion"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:2000405", "pubmed": 18842892, "qualifier": "involved_in", "term": "negative regulation of T cell migration"}], "CC": [{"evidence": "HDA", "gocategory": "CC", "id": "GO:0005576", "pubmed": 27068509, "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0005576", "pubmed": 14718574, "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005576", "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0005615", "pubmed": [16502470, 20551380], "qualifier": "located_in", "term": "extracellular space"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005615", "pubmed": 21705670, "qualifier": "located_in", "term": "extracellular space"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005737", "qualifier": "is_active_in", "term": "cytoplasm"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005783", "qualifier": "located_in", "term": "endoplasmic reticulum"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0022626", "qualifier": "located_in", "term": "cytosolic ribosome"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0030425", "qualifier": "located_in", "term": "dendrite"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0043025", "qualifier": "located_in", "term": "neuronal cell body"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0048471", "pubmed": 14551159, "qualifier": "located_in", "term": "perinuclear region of cytoplasm"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0070062", "pubmed": [19056867, 23533145], "qualifier": "located_in", "term": "extracellular exosome"}], "MF": [{"category": "MF", "evidence": "NAS", "id": "GO:0005319", "pubmed": 3453108, "qualifier": "enables", "term": "lipid transporter activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [7918467, 25416956, 25910212, 31515488, 32296183], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0015485", "qualifier": "enables", "term": "cholesterol binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0015485", "pubmed": 9278274, "qualifier": "enables", "term": "cholesterol binding"}]}, "homologene": {"genes": [[7165, 1280247], [7227, 33324], [7955, 567972], [7955, 767642], [9031, 424893], [9544, 709223], [9598, 460951], [9606, 347], [9615, 478604], [9913, 613972], [10090, 11815], [10116, 25239]], "id": 1246}, "interpro": [{"desc": "Lipocalin/cytosolic fatty-acid binding domain", "id": "IPR000566", "short_desc": "Lipocln_cytosolic_FA-bd_dom"}, {"desc": "Apolipoprotein D", "id": "IPR002969", "short_desc": "ApolipopD"}, {"desc": "Calycin", "id": "IPR012674", "short_desc": "Calycin"}, {"desc": "Lipocalin, ApoD type", "id": "IPR022271", "short_desc": "Lipocalin_ApoD"}, {"desc": "Lipocalin family conserved site", "id": "IPR022272", "short_desc": "Lipocalin_CS"}, {"desc": "Apolipoprotein D, vertebrates", "id": "IPR026222", "short_desc": "ApoD_vertbrte"}], "ipi": ["IPI00006662", "IPI00924574", "IPI00927707", "IPI00927914"], "map_location": "3q29", "name": "apolipoprotein D", "other_names": ["apo-D", "apolipoprotein D"], "pantherdb": {"HGNC": "612", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "88056", "ortholog_type": "LDO", "panther_family": "PTHR10612", "taxid": 10090, "uniprot_kb": "P51910"}, {"RGD": "2137", "ortholog_type": "LDO", "panther_family": "PTHR10612", "taxid": 10116, "uniprot_kb": "P23593"}, {"Ensembl": "ENSGALG00000006995", "ortholog_type": "LDO", "panther_family": "PTHR10612", "taxid": 9031, "uniprot_kb": "Q5G8Y9"}, {"ZFIN": "ZDB-GENE-060929-148", "ortholog_type": "O", "panther_family": "PTHR10612", "taxid": 7955, "uniprot_kb": "F1R0I2"}, {"ZFIN": "ZDB-GENE-070912-551", "ortholog_type": "O", "panther_family": "PTHR10612", "taxid": 7955, "uniprot_kb": "E7F2R8"}, {"ZFIN": "ZDB-GENE-051023-8", "ortholog_type": "LDO", "panther_family": "PTHR10612", "taxid": 7955, "uniprot_kb": "F1QDM9"}, {"FlyBase": "FBgn0051659", "ortholog_type": "LDO", "panther_family": "PTHR10612", "taxid": 7227, "uniprot_kb": "Q8IPX4"}, {"FlyBase": "FBgn0030334", "ortholog_type": "O", "panther_family": "PTHR10612", "taxid": 7227, "uniprot_kb": "Q9VYU5"}, {"FlyBase": "FBgn0033799", "ortholog_type": "O", "panther_family": "PTHR10612", "taxid": 7227, "uniprot_kb": "A1Z991"}, {"FlyBase": "FBgn0053126", "ortholog_type": "O", "panther_family": "PTHR10612", "taxid": 7227, "uniprot_kb": "M9PBN2"}, {"TAIR": "2155831", "ortholog_type": "LDO", "panther_family": "PTHR10612", "taxid": 3702, "uniprot_kb": "Q9FGT8"}], "uniprot_kb": "P05090"}, "pathway": {"reactome": [{"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-382551", "name": "Transport of small molecules"}, {"id": "R-HSA-425397", "name": "Transport of vitamins, nucleosides, and related molecules"}, {"id": "R-HSA-425407", "name": "SLC-mediated transmembrane transport"}, {"id": "R-HSA-804914", "name": "Transport of fatty acids"}, {"id": "R-HSA-9006931", "name": "Signaling by Nuclear Receptors"}, {"id": "R-HSA-9024446", "name": "NR1H2 and NR1H3-mediated signaling"}, {"id": "R-HSA-9029569", "name": "NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux"}]}, "pdb": ["2HZQ", "2HZR"], "pfam": "PF08212", "pharmgkb": "PA24900", "pharos": {"target_id": 15501, "tdl": "Tbio"}, "pir": "A26958", "reagent": {"CM-LibrX-no-seq": [{"id": "GNF325786", "relationship": "is"}, {"id": "GNF325787", "relationship": "is"}, {"id": "GNF325788", "relationship": "is"}], "GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF167298", "relationship": "is"}, {"id": "GNF178204", "relationship": "is"}, {"id": "GNF189110", "relationship": "is"}, {"id": "GNF200016", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF163669", "relationship": "is"}, "GNF_hs-Origene": {"id": "GNF031130", "relationship": "weakly similar to"}, "GNF_mm+hs-MGC": {"id": "GNF000608", "relationship": "is"}, "MasterSecretomicsList": [{"id": "GNF329819", "relationship": "is"}, {"id": "GNF331334", "relationship": "is"}, {"id": "GNF332930", "relationship": "is"}], "NIBRI_hs-Secretome_pDEST": {"id": "GNF337584", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF098170", "relationship": "is"}, {"id": "GNF137825", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000003.12", "NC_060927.1"], "protein": "NP_001638.1", "rna": "NM_001647.4", "translation": {"protein": "NP_001638.1", "rna": "NM_001647.4"}}, "reporter": {"HG-U133_Plus_2": "201525_at", "HG-U95Av2": "36681_at", "HTA-2_0": "TC03002146.hg.1", "HuEx-1_0": "4054204", "HuGene-1_1": "8092970", "HuGene-2_1": "16963113"}, "summary": "This gene encodes a component of high density lipoprotein that has no marked similarity to other apolipoprotein sequences. It has a high degree of homology to plasma retinol-binding protein and other members of the alpha 2 microglobulin protein superfamily of carrier proteins, also known as lipocalins. This glycoprotein is closely associated with the enzyme lecithin:cholesterol acyltransferase - an enzyme involved in lipoprotein metabolism. [provided by RefSeq, Aug 2008].", "symbol": "APOD", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1412480"}, "unigene": "Hs.522555", "uniprot": {"Swiss-Prot": "P05090", "TrEMBL": ["C9JF17", "F8WBT9", "C9JX71"]}, "wikipedia": {"url_stub": "Apolipoprotein D"}}